In this issue of JAMA Ophthalmology, Steptoe and associates present another in their series of articles dealing with ocular lesions found in survivors of the 2013-2016 outbreak of Ebola virus disease (EVD) in West Africa.1 They describe fundus changes that had occurred over a 1-year period among a cohort of 57 survivors of EVD whose median posthospitalization interval was slightly more than 2 years. This article expands on their June 2018 article2 about selected individuals from their primary cohort of 82 survivors of EVD; we also provided commentary about that article.3 Ebola virus disease has continued to be a major public health problem since those articles were published.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rimoin AW, Holland GN. Further Considerations About the Ophthalmic Sequelae of Ebola. JAMA Ophthalmol. 2020;138(4):403–404. doi:10.1001/jamaophthalmol.2020.0185
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: